CRESCENT BIOPHARMA INC (CBIO) Stock Income Statement
NASDAQ:CBIO - Nasdaq - US38000Q1022 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 10.00K | 80.00K | 1.16M | 10.16M | |||
| Cost Of Goods | N/A | N/A | 798.00K | 7.38M | 9.16M | |||
| Gross Profit | N/A | N/A | -4.00K | -42.00K | 11.79M | |||
| Operating Expenses | 32.51M | 39.29M | 47.48M | 64.61M | 61.67M | |||
| Research and Development | 14.26M | 20.07M | 28.39M | 47.49M | 44.93M | |||
| Selling, General, and Administrative Expenses | 18.25M | 19.21M | 19.09M | 17.12M | 16.74M | |||
| Operating Income | -32.51M | -39.28M | -47.40M | -63.45M | -51.51M | |||
| Interest Income/Expense | 935.30K | 2.38M | 710.00K | 20.00K | 480.00K | |||
| Other Income/Expense | N/A | N/A | 0.00 | -78.00K | 570.00K | |||
| Non Recurring Items | -7.53M | N/A | 20.98M | N/A | -800.00K | |||
| Income Before Taxes | -37.88M | -36.90M | -46.69M | -63.43M | -51.03M | |||
| Income Tax | N/A | N/A | 348.00K | N/A | N/A | |||
| Net Income | -37.88M | -36.90M | -46.69M | -63.43M | -51.03M | |||
| EBITDA | -32.47M | -39.12M | -47.19M | -63.19M | -51.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.59 | -0.58 | -0.89 | -1.23 | -1.12 | |||
| Non GAAP EPS | N/A | -0.58 | -0.88 | -1.23 | -1.11 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | -5.00% | -3.62% | 116.04% | |||
| Profit Margin | N/A | -368994.00% | -58362.50% | -5468.10% | -502.26% | |||
| Operating Profit Margin | N/A | -392753.00% | -59250.00% | -5469.83% | -506.99% | |||
All data in USD